首页> 外文期刊>Radiation oncology >Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma
【24h】

Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma

机译:螺旋断层扫描,VMAT,固定场IMRT和3D适形放疗对I-II期鼻部自然杀伤性T细胞淋巴瘤的剂量学比较

获取原文
           

摘要

Background The aim of this study was to compare radiotherapy plans for Stage I-II nasal natural killer/T-cell lymphoma (NNKTL) using helical tomotherapy (HT), volumetric-modulated arc therapy (VMAT), Fixed-Field intensity-modulated radiotherapy (IMRT), and three-dimensional conformal radiotherapy (3D-CRT). Methods Eight patents with Stage I-II NNKTL treated with IMRT were re-planned for HT, VMAT (two full arcs), and 3D-CRT. The quality of target coverage, the exposure of normal tissue and the efficiency of radiation delivery were analyzed. Results HT showed significant improvement over IMRT in terms of D98%, cold spot volume and homogeneity index (HI) of planning target volume (PTV). VMAT provided best dose uniformity ( p =?0.000) to PTV, while HT had best dose homogeneity among the four radiotherapy techniques ( p =?0.000) to PTV. VMAT obviously reduced treatment time ( p =?0.010; 0.000) compared to HT and IMRT. Mean dose of left and right optic nerve was significantly reduced by IMRT compared to HT (19.86%, p =?0.000; 21.40%, p =?0.002) and VMAT (8.97%, p =?0.002; 9.35%, p =?0.001), and maximum dose of left lens of VMAT increased over the HT (36.25%, p =?0.043) and IMRT (40.65%, p =?0.001). Conclusion The unexpected results show that both HT and VMAT can achieve higher conformal treatment plans while getting worse organs at risk (OARs) sparing than IMRT for patients with Stage I-II NNKTL. VMAT requires the shortest delivery time, and IMRT delivers the lowest dose to most OARs. The results could provide guidance for selecting proper radiation technologies for different cases.
机译:背景本研究的目的是比较使用螺旋断层扫描(HT),体积调制弧光治疗(VMAT),固定场强度调制放射治疗的I-II期鼻部自然杀手/ T细胞淋巴瘤(NNKTL)的放射治疗计划(IMRT)和三维保形放射疗法(3D-CRT)。方法对经IMRT治疗的I-II期NNKTL阶段的8项专利进行了HT,VMAT(两个完整弧线)和3D-CRT的重新计划。分析了靶标覆盖的质量,正常组织的暴露量和辐射传递的效率。结果HT在D 98%,冷点量和计划目标量(PTV)的均一性指数(HI)方面均比IMRT有显着改善。 VMAT为PTV提供了最佳的剂量均匀性(p = 0.000),而HT在PTV的四种放疗技术中(p = 0.000)具有最佳的剂量均一性。与HT和IMRT相比,VMAT明显缩短了治疗时间(p =?0.010; 0.000)。 IMRT与HT(19.86%,p =?0.000; 21.40%,p =?0.002)和VMAT(8.97%,p =?0.002; 9.35%,p =?)相比,IMRT显着降低了左右视神经的平均剂量。 0.001),并且VMAT的左晶状体最大剂量超过HT(36.25%,p =±0.043)和IMRT(40.65%,p =±0.001)。结论出乎意料的结果表明,对于I-II期NNKTL患者,与IMRT相比,HT和VMAT均可实现更高的适形治疗计划,同时获得比IMRT更差的危险器官(OAR)储备。 VMAT需要最短的交货时间,而IMRT向大多数OAR输送的剂量最低。结果可为选择适合不同情况的辐射技术提供指导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号